Global Sepsis Therapeutics Market to Reach $433.2 Billion by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Sepsis Therapeutics Industry" - https://www.reportlinker.com/p06051306/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Sepsis Therapeutics Market to Reach $433.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Sepsis Therapeutics estimated at US$3.9 Billion in the year 2022, is projected to reach a revised size of US$433.2 Billion by 2030, growing at a CAGR of 80.4% over the period 2022-2030.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 74.2% CAGR

The Sepsis Therapeutics market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$59.1 Billion by the year 2030 trailing a CAGR of 74.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 70.3% and 67.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 63% CAGR.

Select Competitors (Total 24 Featured)
- Adrenomed AG
- AM-Pharma B.V.
- Aridis Pharmaceuticals Inc.
- Asahi Kasei Pharma America
- Astellas Pharma Inc.
- Endacea Inc.
- InflaRx GmbH
- La Jolla Pharmaceutical Company
- Opsonix, Inc.
- T2 Biosystems Inc.
- TaiRx Inc.


Read the full report: https://www.reportlinker.com/p06051306/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Sepsis - A Prelude
Recent Market Activity
New Treatment Protocols and New Definitions - Every Minute
Counts!!
Aging Population: A Key Growth Driver for Sepsis Therapeutics
Antibiotics and Vasopressors - The Current Standard of Care
Current Categories of Antibacterial Agents for First-line
Sepsis Treatment
Current Anti-bacterial Drugs used in Sepsis
Current Antifungals used for Sepsis
Current Antivirals used for Sepsis
GIAPREZA - The Only FDA Approved Branded Drug for Sepsis Treatment
Argipressin Gains Approval for Septic Shock in 26 EU countries
Current & Future Analysis
Growth Drivers in a Nutshell
Market Restraints
Sepsis Therapeutics - Global Key Competitors Percentage Market
Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS
Adrenomed AG (Germany)
AM-Pharma B.V. (Netherlands)
AMOMED Pharma GmbH (Austria)
Asahi Kasei Pharma America (USA)
Endacea, Inc. (USA)
InflaRx N.V. (Germany)
La Jolla Pharmaceutical Company (USA)
TaiRx, Inc. (USA)

3. MARKET TRENDS & DRIVERS
A Market Characterized by High Unmet Medical Needs
Research Activity Enables Increased Awareness of Disease
Pathogenesis
Select Sepsis Therapeutics under Phase IV Clinical Trials: As
of 2018
Select Sepsis Therapeutics under Phase III Clinical Trials: 2018
Novel Immune-Specific Modes of Action under Focus
Emphasizing on Endothelial Cell Function
HMGB1 - A Potential Target for Future Therapies
Nanoparticle Systems Demonstrate Potential for Use in Septic
Shock Management
Researchers Employ IL-7 to Increase CD4 and CD8 Immune Cells in
Patients
Hydrocortisone Displays Potential in Septic Shock Treatment
Reduced Levels of Vitamin C Characterize Sepsis Patients
Treatment with Hydrocortisone and Vitamin C Demonstrates
Positive Impact on Mortality Rate
Intravenous Vitamins + Hydrocortisone Therapy Causes Waves in
the Market
Researchers Develop ss-Sepsis-3 Protocol for Evaluation of
Sepsis in Animal Models
World Sepsis Day Aims to Result in Improvement in Sepsis
Management
NSAIDs Demonstrate Potential to Treat Sepsis

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Sepsis Therapeutics Market Analysis of Annual
Sales in US$ Million for Years 2012 through 2030

Table 2: World Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 3: World 8-Year Perspective for Sepsis Therapeutics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 4: USA Recent Past, Current & Future Analysis for Sepsis
Therapeutics by Segment - Sepsis Therapeutics - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

CANADA
Table 5: Canada Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

JAPAN
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 6: Japan Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

CHINA
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 7: China Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

EUROPE
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 8: Europe Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 9: Europe 8-Year Perspective for Sepsis Therapeutics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030

FRANCE
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 10: France Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

GERMANY
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 11: Germany Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

ITALY
Table 12: Italy Recent Past, Current & Future Analysis for
Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

UNITED KINGDOM
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 13: UK Recent Past, Current & Future Analysis for Sepsis
Therapeutics by Segment - Sepsis Therapeutics - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

REST OF EUROPE
Table 14: Rest of Europe Recent Past, Current & Future Analysis
for Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

ASIA-PACIFIC
Sepsis Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 15: Asia-Pacific Recent Past, Current & Future Analysis
for Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

REST OF WORLD
Table 16: Rest of World Recent Past, Current & Future Analysis
for Sepsis Therapeutics by Segment - Sepsis Therapeutics -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06051306/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001